{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:28:04Z","timestamp":1761182884665,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jiac.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T16:47:28Z","timestamp":1412527648000},"page":"752-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin"],"prefix":"10.1016","volume":"20","author":[{"given":"Shigeru","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2014.08.004_bib1","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.jiac.2014.08.004_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"year":"2013","series-title":"Guidelines for the treatment of MRSA infectious diseases","author":"The committee for the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases in the treatment for MRSA infectious diseases (chairperson: Niki Y)","key":"10.1016\/j.jiac.2014.08.004_bib3"},{"key":"10.1016\/j.jiac.2014.08.004_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2334-10-159","article-title":"Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC\u00a0= 2 mg\/L, by the broth microdilution method","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.004_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jiac.2014.08.004_bib6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.01485-12","article-title":"Vancomycin AUC\/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia","volume":"57","author":"Holmes","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.004_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijantimicag.2013.02.014","article-title":"Glycopeptide minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus from 2006-2011 in China","volume":"41","author":"Zhuo","year":"2013","journal-title":"Int J Antimicrob Agents"},{"year":"2013","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. M100\u2013S23","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.jiac.2014.08.004_bib8"},{"key":"10.1016\/j.jiac.2014.08.004_bib9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.004_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/JCM.38.3.1008-1015.2000","article-title":"Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus","volume":"38","author":"Enright","year":"2000","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2014.08.004_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/AAC.45.2.433-438.2001","article-title":"Mutant prevention concentrations (MPC) of fluoroquinolones for clinical isolates of Streptococcus pneumoniae","volume":"45","author":"Blondeau","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.004_bib12","first-page":"3581","article-title":"Genetic characterization of a vancomycin-resistant Staphylococcus aureus isolate from the respiratory tract of a patient in a university hospital in northeastern Iran","volume":"50","author":"Azimian","year":"2012"},{"key":"10.1016\/j.jiac.2014.08.004_bib13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.00039-06","article-title":"Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus","volume":"50","author":"Friedman","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.004_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society and Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2014.08.004_bib15","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2014.08.004_bib16","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00284-011-9868-6","article-title":"Vancomycin-resistance transferability from VanA enterococci to Staphylococcus aureus","volume":"62","author":"de Niederh\u00e4usern","year":"2011","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.jiac.2014.08.004_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus","volume":"41","author":"Cui","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jiac.2014.08.004_bib18","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1099\/jmm.0.022533-0","article-title":"Six cases of daptomycin-non-susceptible Staphylococcus aureus bacteremia in Singapore","volume":"59","author":"Hsu","year":"2010","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.jiac.2014.08.004_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/649793","article-title":"Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001\u20132007","volume":"31","author":"Hult\u00e9n","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2014.08.004_bib20","doi-asserted-by":"crossref","first-page":"e34768","DOI":"10.1371\/journal.pone.0034768","article-title":"High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study","volume":"7","author":"Rolo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2014.08.004_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7883\/yoken.66.416","article-title":"Clinical aspects of infection with methicillin-resistant Staphylococcus aureus USA300 strain, generally regarded as community-acquired, in Japan","volume":"66","author":"Nakamura","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.004_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10156-012-0379-6","article-title":"The emerging ST8 methicillin-resistant Staphylococcus aureus clone in the community in Japan: associated infections, genetic diversity, and comparative genomics","volume":"18","author":"Iwao","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2014.08.004_bib23","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2014.08.004_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2014.08.004_bib25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X14002876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:52:13Z","timestamp":1761159133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X14002876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1341321X14002876"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.08.004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A correlation between reduced susceptibilities to vancomycin and daptomycin among the MRSA isolates selected in mutant selection window of both vancomycin and daptomycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}